Cumberland settles breach-of-contract suit with Melinta/Targanta, receives undisclosed consideration

CUMBERLAND PHARMACEUTICALS INC

Settlement finalized June 16, 2023; case closed in NY Supreme Court.
Company had sought $1M in milestone payments for NDA/sNDA filings.
Defendants obtained license to Company patents for product development.
Original action filed Feb 2022; refiled Nov 2022 after jurisdiction change.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.